ndc,product_name,inactive_ingredient_unii,inactive_ingredient_name,active,prescribable
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",059QF0KO0R,WATER,True,True
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",4QD397987E,HISTIDINE,True,True
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",7T1F30V5YH,POLYSORBATE 20,True,True
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",7YIN7J07X4,TREHALOSE DIHYDRATE,True,True
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",AE28F7PNPL,METHIONINE,True,True
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",X573657P6P,HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE,True,True
50242-132,"TRASTUZUMAB 150 mg in 7.4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Herceptin]",4QD397987E,HISTIDINE,True,True
50242-132,"TRASTUZUMAB 150 mg in 7.4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Herceptin]",7T1F30V5YH,POLYSORBATE 20,True,True
50242-132,"TRASTUZUMAB 150 mg in 7.4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Herceptin]",7YIN7J07X4,TREHALOSE DIHYDRATE,True,True
50242-132,"TRASTUZUMAB 150 mg in 7.4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Herceptin]",X573657P6P,HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE,True,True
ndc,product_name,inactive_ingredient_unii,inactive_ingredient_name,active,prescribable
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",059QF0KO0R,WATER,True,True
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",4QD397987E,HISTIDINE,True,True
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",7T1F30V5YH,POLYSORBATE 20,True,True
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",7YIN7J07X4,TREHALOSE DIHYDRATE,True,True
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",AE28F7PNPL,METHIONINE,True,True
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",X573657P6P,HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE,True,True
50242-132,"TRASTUZUMAB 150 mg in 7.4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Herceptin]",4QD397987E,HISTIDINE,True,True
50242-132,"TRASTUZUMAB 150 mg in 7.4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Herceptin]",7T1F30V5YH,POLYSORBATE 20,True,True
50242-132,"TRASTUZUMAB 150 mg in 7.4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Herceptin]",7YIN7J07X4,TREHALOSE DIHYDRATE,True,True
50242-132,"TRASTUZUMAB 150 mg in 7.4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Herceptin]",X573657P6P,HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE,True,True
ndc,product_name,inactive_ingredient_unii,inactive_ingredient_name
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",059QF0KO0R,WATER
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",4QD397987E,HISTIDINE
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",7T1F30V5YH,POLYSORBATE 20
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",7YIN7J07X4,TREHALOSE DIHYDRATE
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",AE28F7PNPL,METHIONINE
50242-077,"TRASTUZUMAB 600 mg in 5 mL / HYALURONIDASE (HUMAN RECOMBINANT) 10000 U in 5 mL SUBCUTANEOUS INJECTION, SOLUTION [Herceptin Hylecta]",X573657P6P,HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
50242-132,"TRASTUZUMAB 150 mg in 7.4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Herceptin]",4QD397987E,HISTIDINE
50242-132,"TRASTUZUMAB 150 mg in 7.4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Herceptin]",7T1F30V5YH,POLYSORBATE 20
50242-132,"TRASTUZUMAB 150 mg in 7.4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Herceptin]",7YIN7J07X4,TREHALOSE DIHYDRATE
50242-132,"TRASTUZUMAB 150 mg in 7.4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Herceptin]",X573657P6P,HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
